Skip to content
April 24, 2024

Equity.Guru

Investment information for the new generation

Search

Research

There is a dearth of cannabis-related clinical studies, and Khiron Life Sciences (KHRN.V) is putting in the work to change that. Today, the company has begun its pre-clinical medical cannabis studies…
Top tip: You guys out there whining about ‘the market’ being down are finding excuses for the wrong problem. Folks be running about with their hair on fire right…
Khiron Life Sciences (KHRN.C) is the only Colombian cannabis company generating revenue from legal production. We checked. After the acquisition of ILANS and the launch of the cosmeceutical brand,…
Calling the weed market “mature” is like calling Ivanka Trump a trained diplomat. Yes, the sector has attracted bucket loads of institutional money, and there are a few profitable…
Experion Holdings (EXP.V) has expanded into European markets by penning a LOI with a Polish import and distribution company to export medical flower to Poland for scientific purposes. When…
The ability to trust the people you put your money into is of utmost importance. ‘Management’ is oft cited as one of the pillars of a company’s success, but…
The Supreme Cannabis Company (FIRE.T) and Khalifa Kush Enterprises Canada unveiled their first product, KKE Oil today, but don’t tell anyone, okay? We wouldn’t want to piss off the…
Chemesis International’s (CSI.C) subsidiary La Finca Interacviva-Arachna Med SAS has received cultivation licenses for three farms near Bogota, Colombia. These three farms add to Chemesis’ holdings in Latin America…
Buried in a news release discussing a shares-for-cash payment to an acquisition target, Emerald Health (EMH.V) stated Monday it is losing a board member over Health Canada security clearance…
Heritage Cannabis (CANN.C) is back in the headlines Wednesday after announcing plans to acquire a minority stake in EndoCanna, one of California’s leading DNA-testing marijuana companies. The news comes…